Skip to content

Kodiak Sciences Inc KOD CA — Lessee Operating Lease Option To Extend

Similar metrics at other companies

OFG Bancorp logo
OFGNumber of lease extension options
20.0%
Xenon Pharmaceuticals logo
XENEBurnaby British Columbia — Lessee Operating Lease Number Of Renewal Options
20.0%
Zymeworks logo
ZYMECA-BC — Number of renewal options
20.0%
Viking Therapeutics logo
VKTXCA — Operating Lease Expense
$63K
DJT
DJTAdditional Operating Lease Right Of Use Assets And Lease Liabilities
$884.7K
Nuvation Bio logo
NUVBMA — Lessee Operating Lease Expiration Year
2K0.0%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.25B+1,477%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseOptionToExtend.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What does CA — lessee operating lease option to extend mean?
A qualitative or quantitative indicator representing the existence or status of options to extend operating leases for facilities within the specified segment. This metric highlights the company's ability to renew site access without renegotiating new terms. It is critical for evaluating long-term operational continuity and lease management strategy.